Effect of oral antacid administration on the pharmacokinetics of intravenous doxycyline

V. X. Nguyen, David E. Nix, S. Gillikin, J. J. Schentag

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline was studied. In a randomized crossover design, six healthy male volunteers received an infusion of 200 mg of doxycycline hyclate on two occasions separated by 7 days. On one occasion, subjects were given 30 ml of aluminum hydroxide orally four times a day for 4 days, beginning 2 days prior to doxycycline dosing. Blood and urine samples were collected up to 48 and 96 h after the infusion, respectively, and were analyzed by a microbial assay. Values for volume of distribution at steady state, nonrenal clearance, urine recovery, and urine pH were not statistically different among treatment groups. With concomitant antacid therapy, the half-life of intravenous doxycycline was shortened from 16.2 ± 2.6 to 11.2 ± 1.2 h (P = 0.003), and total body clearance increased from 37.4 ± 6.5 to 54.1 ± 12.3 ml/min (P = 0.008). Area under the concentration-time curve for serum was decreased by 18 to 44%, with a 22 to 41% increase in renal clearance. Although the increase in nonrenal clearance ranged from 11 to 128%, the high variability led to a nonsignificant difference (P = 0.07). Concomitant oral antacid therapy may significantly enhance the clearance of intravenous doxycycline.

Original languageEnglish (US)
Pages (from-to)434-436
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume33
Issue number4
StatePublished - 1989
Externally publishedYes

Fingerprint

Antacids
Doxycycline
Oral Administration
Pharmacokinetics
Urine
Aluminum Hydroxide
Cross-Over Studies
Half-Life
Healthy Volunteers
Therapeutics
Kidney
Serum

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Effect of oral antacid administration on the pharmacokinetics of intravenous doxycyline. / Nguyen, V. X.; Nix, David E.; Gillikin, S.; Schentag, J. J.

In: Antimicrobial Agents and Chemotherapy, Vol. 33, No. 4, 1989, p. 434-436.

Research output: Contribution to journalArticle

@article{be5ec84add554c62bb7a542827570378,
title = "Effect of oral antacid administration on the pharmacokinetics of intravenous doxycyline",
abstract = "The effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline was studied. In a randomized crossover design, six healthy male volunteers received an infusion of 200 mg of doxycycline hyclate on two occasions separated by 7 days. On one occasion, subjects were given 30 ml of aluminum hydroxide orally four times a day for 4 days, beginning 2 days prior to doxycycline dosing. Blood and urine samples were collected up to 48 and 96 h after the infusion, respectively, and were analyzed by a microbial assay. Values for volume of distribution at steady state, nonrenal clearance, urine recovery, and urine pH were not statistically different among treatment groups. With concomitant antacid therapy, the half-life of intravenous doxycycline was shortened from 16.2 ± 2.6 to 11.2 ± 1.2 h (P = 0.003), and total body clearance increased from 37.4 ± 6.5 to 54.1 ± 12.3 ml/min (P = 0.008). Area under the concentration-time curve for serum was decreased by 18 to 44{\%}, with a 22 to 41{\%} increase in renal clearance. Although the increase in nonrenal clearance ranged from 11 to 128{\%}, the high variability led to a nonsignificant difference (P = 0.07). Concomitant oral antacid therapy may significantly enhance the clearance of intravenous doxycycline.",
author = "Nguyen, {V. X.} and Nix, {David E.} and S. Gillikin and Schentag, {J. J.}",
year = "1989",
language = "English (US)",
volume = "33",
pages = "434--436",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Effect of oral antacid administration on the pharmacokinetics of intravenous doxycyline

AU - Nguyen, V. X.

AU - Nix, David E.

AU - Gillikin, S.

AU - Schentag, J. J.

PY - 1989

Y1 - 1989

N2 - The effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline was studied. In a randomized crossover design, six healthy male volunteers received an infusion of 200 mg of doxycycline hyclate on two occasions separated by 7 days. On one occasion, subjects were given 30 ml of aluminum hydroxide orally four times a day for 4 days, beginning 2 days prior to doxycycline dosing. Blood and urine samples were collected up to 48 and 96 h after the infusion, respectively, and were analyzed by a microbial assay. Values for volume of distribution at steady state, nonrenal clearance, urine recovery, and urine pH were not statistically different among treatment groups. With concomitant antacid therapy, the half-life of intravenous doxycycline was shortened from 16.2 ± 2.6 to 11.2 ± 1.2 h (P = 0.003), and total body clearance increased from 37.4 ± 6.5 to 54.1 ± 12.3 ml/min (P = 0.008). Area under the concentration-time curve for serum was decreased by 18 to 44%, with a 22 to 41% increase in renal clearance. Although the increase in nonrenal clearance ranged from 11 to 128%, the high variability led to a nonsignificant difference (P = 0.07). Concomitant oral antacid therapy may significantly enhance the clearance of intravenous doxycycline.

AB - The effect of oral antacid administration on the pharmacokinetics of intravenous doxycycline was studied. In a randomized crossover design, six healthy male volunteers received an infusion of 200 mg of doxycycline hyclate on two occasions separated by 7 days. On one occasion, subjects were given 30 ml of aluminum hydroxide orally four times a day for 4 days, beginning 2 days prior to doxycycline dosing. Blood and urine samples were collected up to 48 and 96 h after the infusion, respectively, and were analyzed by a microbial assay. Values for volume of distribution at steady state, nonrenal clearance, urine recovery, and urine pH were not statistically different among treatment groups. With concomitant antacid therapy, the half-life of intravenous doxycycline was shortened from 16.2 ± 2.6 to 11.2 ± 1.2 h (P = 0.003), and total body clearance increased from 37.4 ± 6.5 to 54.1 ± 12.3 ml/min (P = 0.008). Area under the concentration-time curve for serum was decreased by 18 to 44%, with a 22 to 41% increase in renal clearance. Although the increase in nonrenal clearance ranged from 11 to 128%, the high variability led to a nonsignificant difference (P = 0.07). Concomitant oral antacid therapy may significantly enhance the clearance of intravenous doxycycline.

UR - http://www.scopus.com/inward/record.url?scp=0024517711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024517711&partnerID=8YFLogxK

M3 - Article

C2 - 2729939

AN - SCOPUS:0024517711

VL - 33

SP - 434

EP - 436

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 4

ER -